Cancer Cancer
Conditions
Interventions
Participants will be randomised to the intervention or comparator group using 2:1 randomisation. Randomisation will be completed by a staff member independent to the trial using an online software too
Sponsors
Loughborough University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Between 13 and 24 years 2. Receiving at least one of the following treatments for cancer: chemotherapy, radiotherapy, immunotherapy, targeted drug therapy, hormonal therapy) 3. Able to speak and read standard English 4. Have a least one parent or guardian who can speak and read standard English 5. Able to provide informed written consent (and/or assent for those under 16 years) 6. Access to smartphone with Bluetooth capable of hosting mobile applications (Apple iOS 10.0+ and Android OS 4.0+) 7. Living in England, Scotland or Northern Ireland 8. Not already participating in physical activity or lifestyle behavioural change research
Exclusion criteria
Exclusion criteria: 1. Undergoing surgery only 2. Unable or unwilling to provide consent (and/or assent for those under 16 years) 3. Terminal cancer diagnosis 4. Cannot speak and read standard English 5. Do not have access to a smartphone with Bluetooth or the capability of hosting mobile applications (Apple iOS 10.0+ and Android OS 4.0+) 6. Living outside of England, Scotland or Northern Ireland 7. Already participating in physical activity or lifestyle behavioural change research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility and acceptability of the Snacktivity-C™ physical activity intervention according to pre-specified progression criteria for the following outcomes: 1. Proportion of participants who on average completed a minimum of 4 bouts of moderate to vigorous intensity physical activity (MVPA) lasting =2 min each day over 8 weeks, measured using a physical activity tracker 2. Proportion of participants who accumulated a total weekly average of at least 90 mins of total physical activity (all intensities), measured using a physical activity tracker 3. Proportion of participants who reported the intervention helped increase their physical activity behaviours, measured using a single-item questionnaire 4. Number of participants recruited in 6 months compared to target sample size Timepoint(s): End of trial | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Total physical activity measured using a research-grade wrist-worn accelerometer at baseline and 8-week follow up 2. Moderate-vigorous physical activity measured using a research-grade wrist-worn accelerometer at baseline and 8-week follow up 3. Steps measured using a research-grade wrist-worn accelerometer at baseline and 8-week follow up 4. Total physical activity measured using the International Physical Activity Questionnaire (IPAQ) at baseline and 8-week follow up 5. Sedentary time measured using a research-grade wrist-worn accelerometer at baseline and 8-week follow up 6. Fatigue measured using the PedsQL Multidimensional Fatigue Scale at baseline and 8-week follow up 7. Quality of life measured using the PedsQL Cancer Module at baseline and 8-week follow up Process outcomes: 1. Exercise self-efficacy measured using the Self-Efficacy for Exercise (SEE) scale at baseline and 8-week follow up 2. Outcome expectations measured using Outcome Expectations for Exercise Scale at baseline and 8-week follow up 3. Time spent on the SnackApp measured using app data during the intervention period (intervention group only) 4. Participant’s experiences of the Snacktivity-C™ intervention, measured using semi-structured interviews post-follow-up (intervention group only) | — |
Countries
United Kingdom
Outcome results
None listed